sotalol has been researched along with Marfan Syndrome in 1 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Marfan Syndrome: An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE, dilation of the AORTA, and aortic dissection. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome (type 1) is associated with mutations in the gene encoding FIBRILLIN-1 (FBN1), a major element of extracellular microfibrils of connective tissue. Mutations in the gene encoding TYPE II TGF-BETA RECEPTOR (TGFBR2) are associated with Marfan syndrome type 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sotalol was partially effective for AVRT, however, it did not prevent AF, RF ablation cured all arrythmias." | 5.35 | [Sotalol prevents atrio-ventricular tachycardia but not atrial fibrillation with rapid ventricular response in a patient wiht WPW syndrome]. ( Bodalski, R; Orczykowski, M; Szufladowicz, E; Szumowski, L; Walczak, F; Zakrzewska-Koperska, J, 2008) |
| "Sotalol was partially effective for AVRT, however, it did not prevent AF, RF ablation cured all arrythmias." | 1.35 | [Sotalol prevents atrio-ventricular tachycardia but not atrial fibrillation with rapid ventricular response in a patient wiht WPW syndrome]. ( Bodalski, R; Orczykowski, M; Szufladowicz, E; Szumowski, L; Walczak, F; Zakrzewska-Koperska, J, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orczykowski, M | 1 |
| Szumowski, L | 1 |
| Szufladowicz, E | 1 |
| Bodalski, R | 1 |
| Zakrzewska-Koperska, J | 1 |
| Walczak, F | 1 |
1 other study available for sotalol and Marfan Syndrome
| Article | Year |
|---|---|
[Sotalol prevents atrio-ventricular tachycardia but not atrial fibrillation with rapid ventricular response in a patient wiht WPW syndrome].
Topics: Adult; Anti-Arrhythmia Agents; Catheter Ablation; Electrocardiography; Humans; Male; Marfan Syndrome | 2008 |